118 related articles for article (PubMed ID: 28045742)
1. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: Complications and reversal strategies as compared to warfarin therapy.
Myers SP; Dadashzadeh ER; Cheung J; Alarcon L; Kutcher M; Brown JB; Neal MD
J Trauma Acute Care Surg; 2017 Mar; 82(3):542-549. PubMed ID: 28045742
[TBL] [Abstract][Full Text] [Related]
2. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia.
Rockhold M; Kunkel L; Lacoste JL; Szymanski T; Rothenberg P; Zimmerman P; Minc S
J Vasc Surg; 2024 Jun; 79(6):1466-1472.e1. PubMed ID: 38278371
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer.
Streiff MB; Milentijevic D; McCrae K; Yannicelli D; Fortier J; Nelson WW; Laliberté F; Crivera C; Lefebvre P; Schein J; Khorana AA
Am J Hematol; 2018 May; 93(5):664-671. PubMed ID: 29396864
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
5. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
Chatani R; Yamashita Y; Morimoto T; Kaneda K; Mushiake K; Kadota K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Kimura T;
Eur J Intern Med; 2024 May; 123():72-80. PubMed ID: 38278660
[TBL] [Abstract][Full Text] [Related]
6. A real-world study of different doses of rivaroxaban in patients with nonvalvular atrial fibrillation.
Yan X; Zhang L; Zhang D; Wang X
Medicine (Baltimore); 2024 Apr; 103(17):e38053. PubMed ID: 38669357
[TBL] [Abstract][Full Text] [Related]
7. Reversal or Repletion Treatment Strategies and Outcomes of Patients With Major Bleeding Events Managed in the Emergency Department: Large Real-Life Investigation in the Northwestern Healthcare District of Tuscany.
Conti A; Leorin M; Bogazzi IC; Renzi N; Pepe G; Frosini F; Furesi L; Dalla Tomasina L; Pennati P; Ghiadoni L;
Crit Pathw Cardiol; 2024 Jun; 23(2):58-72. PubMed ID: 38781079
[TBL] [Abstract][Full Text] [Related]
8. Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis.
Milling TJ; Clark CL; Feronti C; Song SS; Torbati SS; Fermann GJ; Weiss J; Patel D
Am J Emerg Med; 2018 Mar; 36(3):396-402. PubMed ID: 28843518
[TBL] [Abstract][Full Text] [Related]
9. Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation.
Chen G; Chen J; Zhao Q; Zhu Y
Drug Des Devel Ther; 2024; 18():1573-1582. PubMed ID: 38765878
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial.
Castle J; Blower E; Bundred NJ; Harvey JR; Thachil J; Marshall A; Cox K; Cicconi S; Holcombe C; Palmieri C; Kirwan CC
Trials; 2020 Aug; 21(1):749. PubMed ID: 32854772
[TBL] [Abstract][Full Text] [Related]
11. Are geriatric transfer patients with traumatic brain injury at risk for worse outcomes compared to non-geriatric? Propensity-matched study.
Wycech Knight J; Fokin AA; Menzione N; Rabinowitz SR; Viitaniemi SA; Puente I
Brain Inj; 2024 Jul; 38(8):659-667. PubMed ID: 38568043
[TBL] [Abstract][Full Text] [Related]
12. Oral Rivaroxaban Versus Warfarin After inferior Vena cava Filter Implantation: A Retrospective Cohort Study.
Schastlivtsev I; Pankov A; Tsaplin S; Stepanov E; Zhuravlev S; Lobastov K
Clin Appl Thromb Hemost; 2024; 30():10760296241256938. PubMed ID: 38778542
[TBL] [Abstract][Full Text] [Related]
13. Time to oral anticoagulant reversal in intracranial hemorrhage with an emergency medicine pharmacist presence.
Hutcheson B; Spetz S; Davenport J; Shuler E
Am J Emerg Med; 2024 Jun; 80():114-118. PubMed ID: 38547626
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes.
Scotti P; Séguin C; Lo BWY; de Guise E; Troquet JM; Marcoux J
J Neurosurg; 2019 Jul; 133(2):486-495. PubMed ID: 31277068
[TBL] [Abstract][Full Text] [Related]
15. Common P-glycoprotein (
Slišković AM; Palić J; Božina T; Ganoci L; Vrkić Kirhmajer M; Trkulja V; Bulum J; Šimičević L
Biochem Med (Zagreb); 2024 Jun; 34(2):020703. PubMed ID: 38665866
[TBL] [Abstract][Full Text] [Related]
16. Warfarin, not direct oral anticoagulants nor antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: implications in this new era of novel anticoagulants: An EAST Multicenter study.
Anandalwar SP; O'Meara L; Vesselinov R; Zhang A; Baum JN; Cooper A; Decker C; Schroeppel T; Cai J; Cullinane D; Catalano RD; Bugaev N; LeClair M; Feather C; McBride K; Sams V; Leung PS; Olafson S; Callahan DS; Posluszny J; Moradian S; Estroff J; Hochman B; Coleman N; Goldenberg-Sandau A; Nahmias J; Rosenbaum K; Pasley J; Boll L; Hustad L; Reynolds J; Truitt M; Ghneim M
J Trauma Acute Care Surg; 2024 Apr; ():. PubMed ID: 38595274
[TBL] [Abstract][Full Text] [Related]
17. The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases.
Hamada S; Muramoto K; Akaike K; Okabayashi H; Masunaga A; Tomita Y; Ichiyasu H; Sakagami T
Sci Rep; 2024 Feb; 14(1):4039. PubMed ID: 38369531
[TBL] [Abstract][Full Text] [Related]
18. Telemedicine-based medical care compared to in-person medical care for warfarin follow-up: A retrospective propensity score matching cohort study.
Alkhuzaee F; Alsharif S; Shukry M
Am J Health Syst Pharm; 2024 Mar; 81(7):e166-e173. PubMed ID: 38070197
[TBL] [Abstract][Full Text] [Related]
19. Fatal intracranial haemorrhage in a hypertensive patient with atrial fibrillation and coronavirus disease 2019.
Krzystanek E; Gawryluk J; Arkuszewski M
Neuroradiol J; 2021 Apr; 34(2):147-150. PubMed ID: 33307996
[TBL] [Abstract][Full Text] [Related]
20. Acute cholecystitis and gallbladder perforation leading to massive haemoperitoneum in a patient taking rivaroxaban.
Kwok A; Chern TY; Winn R
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30373899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
